v3 Template
G

Geron Corporation

Biotechnology / Healthcare New York, NY, USA ~540 employees
Founded
--
Employees (Est.)
~540
27 leaders known
Total Funding
$1.1B
Funding Rounds
5
Last Funding
2024-11-07

About Geron Corporation

Geron is a biopharmaceutical company focused on changing the course of blood cancers through pioneering science. Their ambition is to extend and enhance patients' lives by advancing innovative medicines for hematologic malignancies.

Products & Services

Medicines:Geron has a medicine approved for use in the United States, aimed at treating blood cancer-related conditions.
Research & Development:Developing innovative medicines specifically targeting myeloid hematologic malignancies.

Specialties

Blood Cancer Treatment Telomerase Inhibition Myeloid Hematologic Malignancies Clinical Trials

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt and Royalty Financing
T: -
FT: Debt and Royalty Financing
A: 375000000
MR: -
FA: Up to $375 million
FAN: 375000000
D: 2024-11-07
FD: 2024-11-07
2 investors
2 RT: Underwritten Offering
T: -
FT: Underwritten Offering
A: 150000000
MR: -
FA: $150.0 million
FAN: 150000000
D: 2024-03-19
FD: 2024-03-19
10 investors
3 RT: Public Offering of Common Stock and Pre-Funded Warrants
T: -
FT: Public Offering of Common Stock and Pre-Funded Warrants
A: 227800000
MR: -
FA: $227.8 million
FAN: 227800000
D: 2023-01-10
FD: 2023-01-10
6 investors
4 RT: Public Offering
T: -
FT: Public Offering
A: 198100000
MR: -
FA: approximately $198.1 million
FAN: 198100000
D: 2023-01-06
FD: 2023-01-06
6 investors
5 RT: Public Offering
T: -
FT: Public Offering
A: 175000000
MR: -
FA: $175 million
FAN: 175000000
D: 2023-01-04
FD: 2023-01-04
6 investors
Debt and Royalty Financing Latest
2024-11-07
$375.0M
2 investors (Pro only)
Underwritten Offering 2024-03-19
$150.0M
Public Offering of Common Stock and Pre-Funded Warrants 2023-01-10
$227.8M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

H

Herman Muller

L

Leonard Hayflick

J

James Watson

A

Alexei Olovnikov

E

Elizabeth Blackburn

Scientist and Nobel Laureate

E

Elizabeth H. Blackburn

Nobel Laureate in Physiology or Medicine

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

Geron Corporation Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
geron.com
Industries
Biotechnology / Healthcare
Company Size
~540 employees (est.)
Locations
New York, NY, USA
NEW YORK, United States
New York, USA +1 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro